[Prostate cancer reporting: needle biopsy and radical prostatectomy specimen].
Tóth E, Salamon F.
Magy Onkol. 2019 Mar 19;63(1):10-15. Epub 2019 Jan 15.
Inflammation on Prostate Needle Biopsy is Associated with Lower Prostate Cancer Risk: A Meta-Analysis.
Vasavada SR, Dobbs RW, Kajdacsy-Balla AA, Abern MR, Moreira DM.
J Urol. 2018 May;199(5):1174-1181. doi: 10.1016/j.juro.2017.11.120. Epub 2017 Dec 12.
Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens.
Grignon DJ.
Mod Pathol. 2018 Jan;31(S1):S96-109. doi: 10.1038/modpathol.2017.167.
Evaluating prostate needle biopsy: therapeutic and prognostic importance.
Bostwick DG.
CA Cancer J Clin. 1997 Sep-Oct;47(5):297-319. doi: 10.3322/canjclin.47.5.297.
Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy.
Epstein JI.
Mod Pathol. 2004 Mar;17(3):307-15. doi: 10.1038/modpathol.3800050.
Diagnosis of adenocarcinoma in prostate needle biopsy tissue.
Humphrey PA.
J Clin Pathol. 2007 Jan;60(1):35-42. doi: 10.1136/jcp.2005.036442.
Fine needle aspiration biopsy of the prostate gland.
Maksem JA, Berner A, Bedrossian C.
Diagn Cytopathol. 2007 Dec;35(12):778-85. doi: 10.1002/dc.20764.
Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population.
Bismar TA, Lewis JS Jr, Vollmer RT, Humphrey PA.
Am J Surg Pathol. 2003 Apr;27(4):432-40. doi: 10.1097/00000478-200304000-00002.
The new frontier of prostate biopsy: determining the role of image-guidance in moving the needle.
Fletcher SA, Berg S, Trinh QD.
BJU Int. 2018 Jan;121(1):4-5. doi: 10.1111/bju.14052.
Fine-needle aspiration biopsy in prostate cancer.
Koizumi JH.
Semin Urol. 1990 Feb;8(1):19-30.
